Scientists at Children’s Hospital Los Angeles develop newer CAR T therapy that promises to be more effective and less toxic for children with neuroblastoma.
A special celebration and research seminar honoring Robert C. Seeger, MD, was held at the Saban Research Institute on August 23, 2017. Seeger, who joined CHLA in 1989 as research director in the
The Children’s Center for Cancer and Blood Diseases (CCCBD) at Children’s Hospital Los Angeles is one of the first sites in the world to offer a promising new investigational therapy to treat
Grants from the St. Baldrick's Foundation are among the most competitive in the field of pediatric cancer. Since 2005, Children's Hospital Los Angeles has received nearly $7.4 million in philanthropic
Investigators at the Children’s Center for Cancer and Blood Diseases at Children’s Hospital Los Angeles provide preclinical evidence that the presence of tumor-associated macrophages—a type of immune
Investigators at the Children’s Center for Cancer and Blood Diseases at Children’s Hospital Los Angeles have identified new findings about an immune cell – called a tumor-associated macrophage – that